Category: Business conditions
-
Pfizer Slashes R&D Funding, Closes U.K. Research Site
Pfizer Inc. in New York said today it plans to cut its research and development spending to keep R&D costs in line with lower expected revenues in 2012. The reductions, which Pfizer calls “significant,” include closing its research facility in Sandwich, U.K. and consolidating research operations in the northeast U.S. The company has lowered its…
-
Heart Disease Treatment Cost Expected to Triple by 2030
An economic forecast by an American Heart Association (AHA) panel indicates that the cost to treat heart disease in the United States is expected to triple to $818 billion by 2030 from $273 billion in 2010. The findings are contained in a policy statement published in the online issue of Circulation: Journal of the American…
-
Study: Energy Dept Lab Generates $271 Million for State
An economic study estimates that the Thomas Jefferson National Accelerator Facility, a U.S. Department of Energy nuclear physics research laboratory in Newport News, Virginia, generates more than $271 million in economic output and 2,200 jobs in Virginia. The study for Jefferson Science Associates LLC, the contract operators of the lab, was conducted by The Wessex…
-
Report: Tech Industry Clusters Help Build Regional Economies
A new report from the Brookings Institution, a public policy research institute in Washington, D.C., urges the nation’s governors to create innovative new businesses in their states by building on current clusters of enterprises rather than trying to steal companies from other states. The report says this strategy, documented with examples of science and technology-based…
-
U.S. Cancer Care Costs to Rise 39 Pct by 2020
The cost of caring for U.S. cancer patients is expected to rise sharply in the 2010 to 2020 decade, according to an analysis published online in the Journal of the National Cancer Institute. The combination of population aging and rising expense rates are projected to push the cost for cancer care to $173 billion, a…
-
Danish Pharma Company Restructures, Cuts Workforce
NeuroSearch, a biopharmaceutical company in Copenhagen, Denmark said today the company would restructure its operations to focus more on developing drugs for the central nervous system. This reorganization of the enterprise, says NeuroSearch, will lead to a 20 percent reduction in its workforce. The goal of the restructuring is to accelerate development of its lead…
-
Report: Nanotech Can Cut Green Energy Costs
In a new report, a technology research company estimates the use of available nanotechnologies can significantly reduce the cost of producing energy from renewable sources. ABI Research in New York says that worldwide investment in renewable energy will top $2 trillion on a cumulative basis from 2010 through 2015, but over that same period using…
-
Consumers Want, Will Pay for Predictive Health Tests
In a national survey conducted by researchers at Tufts Medical Center in Boston, Massachusetts, consumers indicated they place a high value on information to predict their future health, and may be willing to pay out of pocket to get it. The they survey was funded by the Institute for Health Technology Studies. The findings appear…
-
Math Model Developed for Non-Economic Power Costs
A doctoral student in Spain developed a mathematical model for calculating electrical power generation costs, including environmental and societal variables usually difficult to measure. Macarena Larrea at the University of the Basque Country in Usurbil, Spain devised the Electra II mathematical model, as she calls it, in her dissertation for a doctoral degree in engineering.…
-
Survey: Type-2 Diabetes Patients Would Switch from Insulin
A new survey shows 60 percent of type-2 diabetes patients in the U.S. who currently use insulin say they would prefer switching to a less expensive bio-similar insulin if such an agent became available. Decision Resources, a health care industry research firm, conducted the survey of diabetes patients in September 2010. Decision Resources reports most…